ScholarX: Browsing ScholarWorks

Browsing by Paz-Ares, LuisAuthor

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

전체 가 나 다 라 마 바 사 아 자 차 카 타 파 하

Sort by: In order: Results/Page Authors/Record:

Showing results 1 to 15 of 15

SCIESCOPUS

Amivantamab plus Chemotherapy in NSCLC with EGFR Exon 20 Insertions

Zhou, Caicun; Tang, Ke-Jing; Cho, Byoung Chul; Liu, Baogang; Paz-Ares, Luis; Cheng, Susanna; Kitazono, Satoru; Thiagarajan, Muthukkumaran; Goldman, Jonathan W.; Sabari, Joshua K., et al.

ArticleIssue Date2023CitationNEW ENGLAND JOURNAL OF MEDICINE, v.389, no.22, pp 2039 - 2051PublisherMASSACHUSETTS MEDICAL SOC

SCIESCOPUS

Amivantamab Plus Lazertinib in Patients With EGFR-Mutant NSCLC After Progression on Osimertinib and Platinum-Based Chemotherapy: Results From CHRYSALIS-2 Cohort A

Besse, Benjamin; Goto, Koichi; Wang, Yongsheng; Lee, Se-Hoon; Marmarelis, Melina E.; Ohe, Yuichiro; Bernabe Caro, Reyes; Kim, Dong-Wan; Lee, Jong-Seok; Cousin, Sophie, et al.

ArticleIssue Date2025CitationJournal of Thoracic OncologyPublisherElsevier Inc.

SCIESCOPUS

Bintrafusp Alfa Versus Pembrolizumab in Patients With Treatment-Naive, Programmed Death-Ligand 1–High Advanced NSCLC: A Randomized, Open-Label, Phase 3 Trial

Cho, Byoung Chul; Lee, Jong Seok; Wu, Yi-Long; Cicin, Irfan; Dols, Manuel Cobo; Ahn, Myung-Ju; Cuppens, Kristof; Veillon, Rémi; Nadal, Ernest; Dias, Josiane Mourão, et al.

ArticleIssue Date2023CitationJournal of Thoracic Oncology, v.18, no.12, pp 1731 - 1742PublisherElsevier Inc.

SCIESCOPUS

Bintrafusp Alfa With CCRT Followed by Bintrafusp Alfa Versus Placebo With CCRT Followed by Durvalumab in Patients With Unresectable Stage III NSCLC: A Phase 2 Randomized Study open access

Vokes, Everett E.; Mornex, Francoise; Sezer, Ahmet; Cheng, Ying; Fang, Jian; Baz, David Vicente; Cil, Timucin; Adjei, Alex A.; Ahn, Myung-Ju; Barlesi, Fabrice, et al.

ArticleIssue Date2024CitationJournal of Thoracic Oncology, v.19, no.2, pp 285 - 296PublisherElsevier Inc.

SCIESCOPUS

Datopotamab deruxtecan (Dato-DXd) vs docetaxel in previously treated advanced/metastatic (adv/met) non-small cell lung cancer (NSCLC): Results of the randomized phase III study TROPION-Lung01

Atmaca, Akin; Ahn, Myung-Ju; Lisberg, Aaron; Paz-Ares, Luis; Cornelissen, Robin; Girard, Nicolas; Pons-Tostivint, Elvire; Baz, David Vicente; Sugawara, Shunichi; Cobo, Manuel Angel, et al.

ArticleIssue Date2024CitationONCOLOGY RESEARCH AND TREATMENT, v.47, pp 245 - 245PublisherKARGER

SCIESCOPUS

Datopotamab Deruxtecan in Advanced or Metastatic Non–Small Cell Lung Cancer With Actionable Genomic Alterations Results From the Phase II TROPION-Lung05 Study

Sands, Jacob; Ahn, Myung-Ju; Lisberg, Aaron; Cho, Byoung Chul; Blumenschein, George; Shum, Elaine; Tostivint, Elvire Pons; Goto, Yasushi; Yoh, Kiyotaka; Heist, Rebecca, et al.

ArticleIssue Date2025CitationJournal of Clinical Oncology, v.43, no.10PublisherLippincott Williams and Wilkins

SCIESCOPUS

Datopotamab Deruxtecan Versus Docetaxel for Previously Treated Advanced or Metastatic Non-Small Cell Lung Cancer: The Randomized, Open-Label Phase III TROPION-Lung01 Study

Ahn, Myung-Ju; Tanaka, Kentaro; Paz-Ares, Luis; Cornelissen, Robin; Girard, Nicolas; Pons-Tostivint, Elvire; Vicente Baz, David; Sugawara, Shunichi; Cobo, Manuel; Pérol, Maurice, et al.

ArticleIssue Date2025CitationJournal of Clinical Oncology, v.43, no.3PublisherLippincott Williams and Wilkins

SCIESCOPUS

Durvalumab ± Tremelimumab plus Platinum-Etoposide in Extensive-Stage Small Cell Lung Cancer (CASPIAN): Outcomes by PD-L1 Expression and Tissue Tumor Mutational Burden open access

Paz-Ares, Luis; Garassino, Marina Chiara; Chen, Yuanbin; Reinmuth, Niels; Hotta, Katsuyuki; Poltoratskiy, Artem; Trukhin, Dmytro; Hochmair, Maximilian J.; Oezgueroglu, Mustafa; Ji, Jun Ho, et al.

ArticleIssue Date2024CitationCLINICAL CANCER RESEARCH, v.30, no.4, pp 824 - 835PublisherAMER ASSOC CANCER RESEARCH

SCIESCOPUS

Erdafitinib in patients with advanced solid tumours with FGFR alterations (RAGNAR): an international, single-arm, phase 2 study open access

Pant, Shubham; Schuler, Martin; Iyer, Gopa; Witt, Olaf; Doi, Toshihiko; Qin, Shukui; Tabernero, Josep; Reardon, David A; Massard, Christophe; Minchom, Anna, et al.

ArticleIssue Date2023CitationThe Lancet Oncology, v.24, no.8, pp 925 - 935PublisherElsevier Ltd

SCIESCOPUS

HERTHENA-Lung01, a Phase II Trial of Patritumab Deruxtecan (HER3-DXd) in Epidermal Growth Factor Receptor–Mutated Non–Small-Cell Lung Cancer After Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Therapy and Platinum-Based Chemotherapy open access

Yu, Helena A.; Goto, Yasushi; Hayashi, Hidetoshi; Felip, Enriqueta; Chih-Hsin Yang, James; Reck, Martin; Yoh, Kiyotaka; Lee, Se-Hoon; Paz-Ares, Luis; Besse, Benjamin, et al.

ArticleIssue Date2023CitationJournal of Clinical Oncology, v.41, no.35, pp 5363 - 5375PublisherLippincott Williams and Wilkins

SCIESCOPUS

Immune Checkpoint Inhibitors in Thoracic Malignancies: Review of the Existing Evidence by an IASLC Expert Panel and Recommendations open access

Remon, Jordi; Passiglia, Francesco; Ahn, Myung-Ju; Barlesi, Fabrice; Forde, Patrick M.; Garon, Edward B.; Gettinger, Scott; Goldberg, Sarah B.; Herbst, Roy S.; Horn, Leora, et al.

ArticleIssue Date2020CitationJOURNAL OF THORACIC ONCOLOGY, v.15, no.6, pp 914 - 947PublisherELSEVIER SCIENCE INC

SCIESCOPUS

Patient-Reported Outcomes for Patients with Previously Treated Small Cell Lung Cancer Receiving Tarlatamab: Results from the DeLLphi-301 Phase 2 Trial open access

Hummel, Horst-Dieter; Ahn, Myung-Ju; Blackhall, Fiona; Reck, Martin; Akamatsu, Hiroaki; Ramalingam, Suresh S.; Borghaei, Hossein; Johnson, Melissa; Dirnberger, Franziska; Cocks, Kim, et al.

ArticleIssue Date2025CitationADVANCES IN THERAPYPublisherSPRINGER

SCIESCOPUS

Plain language summary: tarlatamab for patients with previously treated small cell lung cancer

"Ahn, Myung-Ju; Cho, Byoung Chul; Felip, Enriqueta; Korantzis, Ippokratis; Ohashi, Kadoaki; Majem, Margarita; Juan-Vidal, Oscar; Handzhiev, Sabin; Izumi, Hiroki; Lee, Jong-Seok, et al.

ArticleIssue Date2024CitationFuture Oncology, v.20, no.40, pp 3355 - 3364PublisherTaylor and Francis Ltd.

SCIESCOPUS

Tarlatamab for Patients with Previously Treated Small-Cell Lung Cancer

Ahn, Myung-Ju; Cho, Byoung Chul; Felip, Enriqueta; Korantzis, Ippokratis; Ohashi, Kadoaki; Majem, Margarita; Juan-Vidal, Oscar; Handzhiev, Sabin; Izumi, Hiroki; Lee, Jong-Seok, et al.

ArticleIssue Date2023CitationNEW ENGLAND JOURNAL OF MEDICINE, v.389, no.22, pp 2063 - 2075PublisherMASSACHUSETTS MEDICAL SOC

SCIESCOPUS

TROPION-Lung05: Datopotamab deruxtecan (Dato-DXd) in previously treated non-small cell lung cancer (NSCLC) with actionable genomic alterations (AGAs)

Atmaca, Akin; Paz-Ares, Luis; Ahn, Myung-Ju; Lisberg, Aaron; Kitazono, Satoru; Cho, Byoung Chul; Blumenschein, George, Jr.; Shum, Elaine; Tostivint, Elvire Pons; Goto, Yasushi, et al.

ArticleIssue Date2024CitationONCOLOGY RESEARCH AND TREATMENT, v.47, pp 127 - 127PublisherKARGER

STATISTICS: Total View:; Daily View:

RSS_1.0 RSS_2.0 ATOM_1.0

(03063) 25-2, SUNGKYUNKWAN-RO, JONGNO-GU, SEOUL, KOREA samsunglib@skku.edu

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

Browsing by Paz-Ares, LuisAuthor

BROWSE